Oncolytic Vaccinia Virus Harboring <i>Aphrocallistes vastus</i> Lectin Inhibits the Growth of Hepatocellular Carcinoma Cells

Oncolytic Vaccinia Virus Harboring <i>Aphrocallistes vastus</i> Lectin Inhibits the Growth of Hepatocellular Carcinoma Cells

Oncolytic vaccinia virus has been developed as a novel cancer therapeutic drug in recent years. Our previous studies demonstrated that the antitumor effect of oncolytic vaccina virus harboring Aphrocallistes vastus lectin (oncoVV-AVL) was significantly enhanced in several cancer cells. In the presen...

Full description

Bibliographic Details
Main Authors: Riqing Jiang, Yufeng Qiu, Xiaomei Zhang, Ningning Zhou, Xiaoyuan Jia, Kan Chen, Yanrong Zhou, Ting Ye, Gongchu Li
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Marine Drugs
Subjects:
oncolytic vaccinia virus
viral replication
<i>Aphrocallistes vastus</i> lectin
Huh7 cells
Online Access:https://www.mdpi.com/1660-3397/20/6/378

Internet

https://www.mdpi.com/1660-3397/20/6/378

Similar Items